DRIO
DarioHealth Corp.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$7.20
+3.00%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.51
- Revenue estimate
- $5.2M
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.85
- EPS estimate
- -$1.22
- Revenue actual
- $5.2M
- Revenue estimate
- $5.8M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +38.2%
- Revenue beats (12Q)
- 2
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $10
- PT range
- $8.00 – $12
- Analysts
- 2
1 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$1.22 | -$0.85 | Beat 30.33% | $5.2M |
| May 13, 2026 | -$1.09 | -$0.81 | Beat 25.69% | $5.6M |
| Mar 19, 2026 | -$2.44 | -$0.80 | Beat 67.21% | $5.2M |
| Nov 13, 2025 | -$2.63 | -$1.85 | Beat 29.66% | $5.0M |
| Aug 12, 2025 | -$2.20 | -$2.40 | Miss -9.09% | $5.4M |
| May 14, 2025 | -$1.40 | -$1.20 | Beat 14.29% | $6.8M |
| Mar 10, 2025 | -$3.20 | $0.20 | Beat 106.25% | $7.6M |
| Nov 7, 2024 | -$3.60 | -$2.60 | Beat 27.78% | $7.4M |
| Aug 8, 2024 | -$5.80 | $1.20 | Beat 120.69% | $6.3M |
| May 15, 2024 | -$12 | -$4.00 | Beat 66.10% | $5.8M |
| Nov 2, 2023 | -$10 | -$9.80 | Beat 2.00% | $3.5M |
| Aug 10, 2023 | -$10 | -$12 | Miss -11.54% | $6.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026